top of page

LL-3R 20mg

$140.00Price
Quantity

Functions as a "triple-agonist," targeting three different hormone receptors (GLP-1, GIP, and glucagon) to suppress appetite, regulate blood sugar, and increase energy expenditure.

In clinical trials, Retatrutide has shown unprecedented weight-loss efficacy, making it one of the most closely watched drugs in development.

Administered once weekly via subcutaneous injection. Dosing starts low and increases over several weeks to improve tolerability. Common maintenance doses range from 1 mg to 12 mg weekly. Dose adjustments are based on tolerability and metabolic response


(Formally Retatrutide/GLP-3RT)


bottom of page